Xiaoxu Li

InstitutionShandong Agricultural University
AddressTai'an
Shandong
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 5 Covid-19 publications, with a maximum of 1 publications in June 2020 and August 2020 and October 2020 and November 2020 and December 2020
    All Publications
    Bar chart showing 80 publications over 19 distinct years, with a maximum of 12 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ju J, Li X, Kumar S, Jockusch S, Chien M, Tao C, Morozova I, Kalachikov S, Kirchdoerfer RN, Russo JJ. Nucleotide analogues as inhibitors of SARS-CoV Polymerase. Pharmacol Res Perspect. 2020 12; 8(6):e00674. PMID: 33124786.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    2. Zhao W, Gao Y, Xu Q, Ding W, Cao D, Xiao Z, Chen J, Yan L, Zhao C, Li X, Chen Y, Chen Q, Chen Y. Buffer wards for the control of COVID-19 transmission in hospitals. Clin Transl Med. 2020 Nov; 10(7):e223. PMID: 33252862.
      Citations: 1     
    3. Jockusch S, Tao C, Li X, Chien M, Kumar S, Morozova I, Kalachikov S, Russo JJ, Ju J. Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir. Sci Rep. 2020 10 06; 10(1):16577. PMID: 33024223.
      Citations: 19     Fields:    Translation:HumansCellsPHPublic Health
    4. Chien M, Anderson TK, Jockusch S, Tao C, Li X, Kumar S, Russo JJ, Kirchdoerfer RN, Ju J. Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19. J Proteome Res. 2020 11 06; 19(11):4690-4697. PMID: 32692185.
      Citations: 73     Fields:    Translation:HumansCellsPHPublic Health
    5. Jockusch S, Tao C, Li X, Anderson TK, Chien M, Kumar S, Russo JJ, Kirchdoerfer RN, Ju J. A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19. Antiviral Res. 2020 08; 180:104857. PMID: 32562705.
      Citations: 29     Fields:    Translation:CellsPHPublic Health